Sabby Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $27.3K | Sell |
|
|||||
|
2023
Q2 | $2.61M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $2.05M | Buy |
|
|||||
|
2021
Q3 | $1.57M | Buy |
|
|||||
|
2021
Q2 | $923K | Buy |
|
|||||
|
2021
Q1 | $523K | Buy |
|
|||||
|
2020
Q4 | – | Hold |
|
|||||
|
2020
Q3 | – | Hold |
|
|||||
|
2020
Q2 | – | Hold |
|
|||||
|
2020
Q1 | – | Hold |
|
|||||
|
2019
Q4 | – | Hold |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $625K | Sell |
|
|||||
|
2019
Q1 | $3.23M | Sell |
|
|||||
|
2018
Q4 | $3.59M | Buy |
|
|||||
|
2018
Q3 | $3.46M | Sell |
|
|||||
|
2018
Q2 | $3.63M | Buy |
|
|||||
|
2018
Q1 | $70K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $70K | Sell |
|
|||||
|
2017
Q1 | $296K | Sell |
|
|||||
|
2016
Q4 | $637K | Sell |
|
|||||
|
2016
Q3 | $1.06M | Sell |
|
|||||
|
2016
Q2 | $1.15M | Sell |
|
|||||
|
2016
Q1 | $1.32M | Sell |
|
|||||
|
2015
Q4 | $2.2M | Sell |
|
|||||
|
2015
Q3 | $1.95M | Buy |
|
|||||
|
2015
Q2 | $2.69M | Sell |
|
|||||
|
2015
Q1 | $6.27M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $3.32K | Buy |
|